Nowadays, due to advances in technology, patients are well informed and connected, and are realizing the power and value of their voice. Stakeholders in clinical trials, like funders, regulators, and healthcare providers are increasingly turning their focus to what patients want. Trial funders are looking for greater evidence of patient input into research to ensure the relevance of the research to patients. Regulators, like EMA and FDA, are increasingly considering the patient perspective in their regulatory decision-making processes. Healthcare providers are well aware of the impact of patients consent on the outcome of their treatments. As a result, patient groups are increasingly recognized as partners in the design and conduct of clinical trials and play an important role in patient recruitment and patient retention in the trials.
This presentation will provide an overview of methods and initiatives in effective engagement of patient groups in the design and conduct of clinical trials.